Hester Biosciences Ltd.
BSE: 524669 | Sector: Health care |
NSE: HESTERBIO | ISIN Code: INE782E01017 |
BSE 00:00 | 13 Apr | 2019.60 |
29.95 (1.51%) |
OPEN
2025.05 |
HIGH
2073.45 |
LOW
1982.00 |
NSE 00:00 | 13 Apr | 2016.75 |
25.15 (1.26%) |
OPEN
2007.55 |
HIGH
2075.00 |
LOW
1979.85 |
OPEN | 2025.05 |
PREVIOUS CLOSE | 1989.65 |
VOLUME | 2144 |
52-Week high | 2279.80 |
52-Week low | 980.00 |
P/E | 47.67 |
Mkt Cap.(Rs cr) | 1,719 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 627.40 | 1.33 | 653.70 | 434.25 | 150532.08 |
Divi's Lab. | 3720.25 | -1.67 | 3913.00 | 2094.60 | 98754.04 |
Dr Reddy's Labs | 4780.60 | -4.18 | 5514.65 | 3610.75 | 79501.38 |
Cipla | 885.20 | -1.97 | 940.00 | 565.90 | 71386.95 |
Aurobindo Pharma | 909.75 | -0.70 | 1023.10 | 464.35 | 53302.25 |
Cadila Health. | 488.55 | -2.28 | 532.05 | 318.10 | 50012.86 |
Biocon | 406.90 | 0.69 | 487.70 | 320.90 | 48828.00 |
Lupin | 1037.15 | -0.82 | 1121.85 | 787.60 | 47055.49 |
Torrent Pharma. | 2566.40 | 0.42 | 3040.00 | 2227.20 | 43428.62 |
Apollo Hospitals | 2978.40 | -1.11 | 3283.90 | 1230.25 | 42823.43 |
Gland Pharma | 2532.05 | -2.45 | 2784.45 | 1701.00 | 41424.34 |
Piramal Enterp. | 1715.00 | 5.27 | 2008.20 | 805.60 | 38681.83 |
Alkem Lab | 2754.60 | 0.36 | 3150.00 | 2223.55 | 32931.24 |
Abbott India | 14958.50 | -0.67 | 18569.00 | 13970.10 | 31786.81 |
Ipca Labs. | 2154.05 | 0.01 | 2455.55 | 1442.65 | 27324.13 |
Glaxosmi. Pharma | 1455.10 | 0.06 | 1805.00 | 1258.00 | 24650.85 |
Dr Lal Pathlabs | 2948.80 | -11.68 | 3398.95 | 1445.50 | 24575.30 |
Laurus Labs | 439.65 | 5.63 | 448.50 | 77.25 | 23591.62 |
Pfizer | 5072.40 | 6.53 | 5875.00 | 3940.00 | 23206.23 |
Syngene Intl. | 564.45 | 2.61 | 644.65 | 270.45 | 22578.00 |
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices